Christopher S. Lynch

This profile gathers the share dealings of Christopher S. Lynch across 3 companies, led by Tenet Healthcare Corp, Corebridge Financial, Inc. and American International Group, Inc. The record holds 21 filings, for trades running from 8 May 2012 to 27 July 2026.

In open-market terms, that means 3 purchases worth €77k on one side and 5 sales worth €3.4M on the other. Taken together, the sales exceed the purchases by €3.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 12 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 1 sale.

A typical purchase (the median) is worth €739.

On 28 July 2026 came the latest disclosure, an open-market sale for €819k in Tenet Healthcare Corp. The last insider purchase was made public on 10 May 2012, 5,296 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.